Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
This intronless gene encodes a carcinoma-associated antigen. Additionally we are shipping TACSTD2 Proteins (16) and TACSTD2 Kits (1) and many more products for this protein.
Showing 10 out of 121 products:
Human Polyclonal TACSTD2 Primary Antibody for EIA, WB - ABIN453439
Goldstein, Lawson, Cheng, Sun, Garraway, Witte: Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. in Proceedings of the National Academy of Sciences of the United States of America 2008
Human Polyclonal TACSTD2 Primary Antibody for WB - ABIN375030
Shimada, Kano, Ishiyama, Okubo, Iijima, Morishita, Minami, Inadome, Shu, Sugita, Takeuchi, Noguchi: Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development. in Cancer science 2005
Trop-2 promotes an alpha5beta1 integrin-dependent pro-metastatic signaling pathway in PCa (show ENPP1 Antibodies) cells and that the altered expression of Trop-2 may be utilized for early identification of capsule-invading PCa (show ENPP1 Antibodies).
studies have begun to identify the mechanisms underlying TROP2's functions, including regulated intramembrane proteolysis or specific interactions with integrin b1 and claudin proteins.
our findings help to establish a close functional link between Trop2 and MSCs, and to provide a tool for future investigation of Trop2 in other types of stem cells
data suggest that Trop2 regulates cell proliferation and motility and that it does so by regulating the ERK (show EPHB2 Antibodies) pathway and several critical components of the cell migration apparatus
Trop2 plays a cardioprotective role by promoting cardiac c-kit (show KIT Antibodies)+ cell proliferation and inhibition of apoptosis in the acute phase of myocardial infarction.
Trop2 is a regulator of self-renewal, proliferation, and transformation
TROP2 modulates the interaction between the cells and matrix and regulates the formation of the ureteric duct by suppressing branching from the trunk during kidney development.
these results uncover a role for Trop2 loss in tumorigenesis and the mesenchymal transdifferentiation observed in a subset of squamous cell carcinomas.
In human and mouse, Trop2 is highly expressed at both the transcript and protein levels on several essential normal tissues.
Study also provides the first indication of a molecular signaling pathway activated by Trop2 which has important implications for cancer cell growth and survival.
Trop-2 is a novel target for ADC (show ADC Antibodies) therapy because of its high expression by many solid cancers.
TROP2 is epigenetically down-regulated and operates as a negative regulator of cell proliferation and migration in liver fluke-associated cholangiocarcinoma.
TROP-2 is specifically expressed in papillary thyroid carcinoma.
overexpression of TROP2 appears to be an independent predictor for poor clinical outcome in nasopharyngeal carcinoma
Lower GA733-2 (show EPCAM Antibodies) expression in cancer tissues appeared to correlate with lymph node metastases (P < 0.05). GA733-1 gene expression was significantly higher in cancerous samples
TROP-2 can be used as well as HBME-1 in thyroid cytology to detect PTC (show F9 Antibodies).
Altogether, our data suggest that TROP2 plays an important role in promoting ADC (show ADC Antibodies) and may represent a novel prognostic biomarker and therapeutic target for the disease.
TROP2 protein is expressed at high levels in the colon cancer tissues.
TACSTD2 protein, human is predicting lymph node metastases in OSCC, overall survival and disease-free survival.
The amino acid exchange resulting from 4461T[C does not appear to alter binding of HO-3 (show HARS2 Antibodies), suggesting that treatment with catumaxomab can be offered to patients regardless of their TACSTD1 (show EPCAM Antibodies)-genotype.
This intronless gene encodes a carcinoma-associated antigen. This antigen is a cell surface receptor that transduces calcium signals. Mutations of this gene have been associated with gelatinous drop-like corneal dystrophy.
tropomyosin beta chain
, 40kD glycoprotein, identified by monoclonal antibody GA733
, cell surface glycoprotein TROP2
, cell surface glycoprotein Trop-2
, epithelial glycoprotein-1
, gastrointestinal tumor-associated antigen GA7331
, membrane component chromosome 1 surface marker 1
, membrane component, chromosome 1, surface marker 1
, pancreatic carcinoma marker protein GA733-1
, pancreatic carcinoma marker protein GA7331
, lymphocyte antigen 97
, tunor-associated calcium signal transducer 2
, parturition-related protein 1